Changes in health-related quality of life for HCV-infected people who inject drugs on opioid agonist treatment following sustained virologic response.
Mirinda Ann GormleyMatthew J AkiyamaLior M RennertKerry A HowardBrianna L NortonIrene Pericot-ValverdeSam MuenchMoonseong HeoAlain H LitwinPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
HCV treatment led to sustained improvement in HRQOL for PWID on OAT who achieved SVR. Future research is necessary to determine whether improvements in HRQOL can be sustained beyond 12-weeks post-SVR.
Keyphrases